{"id":"W2106760090","doi":"10.1160/th15-03-0192","title":"Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran","year":2015,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Idarucizumab; Dabigatran; Medicine; Antithrombins; Intensive care medicine; Surgery; Internal medicine; Warfarin; Heparin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06319097,0.003170247,0.00339011,0.001644057,0.003032275,0.003550368,0.002955092,0.007410278,0.01322249],"category_scores_gemma":[0.04381263,0.002416645,0.002154178,0.0009965289,0.004980114,0.002330393,0.002021978,0.01085806,0.00799635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002207276,"about_ca_system_score_gemma":0.01063994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006812886,"about_ca_topic_score_gemma":0.00183348,"domain_scores_codex":[0.9613668,0.02526249,0.003388954,0.00321596,0.005305603,0.00146016],"domain_scores_gemma":[0.9847323,0.004258833,0.001926834,0.002411377,0.00271396,0.003956659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4245654,0.02678886,0.006943208,0.01164832,0.001698324,0.002547333,0.002667076,0.003923455,0.01976781,0.09137402,0.1072031,0.300873],"study_design_scores_gemma":[0.417785,0.0834861,0.006653045,0.005930108,0.002098067,0.00138544,0.0004176401,0.005263492,0.01019765,0.028829,0.4375577,0.0003967618],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"methods","genre_scores_codex":[0.02205614,0.007075315,0.04460809,0.01953425,0.009786998,0.8704081,0.005193386,0.0008084976,0.02052925],"genre_scores_gemma":[0.06458045,0.003159052,0.08830955,0.01744005,0.003563992,0.8127519,0.001125328,0.0001547537,0.008915009],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.06319097,"threshold_uncertainty_score":0.3341898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4322390599412628,"score_gpt":0.43282895513279,"score_spread":0.0005898951915271899,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}